Who owns Cymabay Therapeutics?
- CUSIP Number: 23257d103
Tip: Access positions for across all investors
Analyze quarterly positions in Cymabay Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cymabay Therapeutics stock
Who bought or sold Cymabay Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| venBio Select Advisor | 11M | $262M | 8% | Dec 2023 |
|
| Nicholas Investments Partners | 435k | $10M | -76% | Dec 2023 |
|
| Alliancebernstein | 350k | $8.3M | 246% | Dec 2023 |
|
| Wellington Management Company | 203k | $4.8M | 100% | Dec 2023 |
|
| Algert Coldiron Investors | 85k | $2.0M | -9% | Dec 2023 |
|
| ALPS Advisors | 75k | $1.8M | 4% | Dec 2023 |
|
| MetLife Investment Advisors | 59k | $1.4M | 15% | Dec 2023 |
|
| American International | 56k | $1.3M | 15% | Dec 2023 |
|
| Golden State Equity Partners | 54k | $1.3M | 9% | Dec 2023 |
|
| Healthcare Of Ontario Pension Plan Trust Fund | 45k | $1.1M | 100% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 6.4k | $152k | 14% | Dec 2023 |
|
| Tucker Asset Management | 3.7k | $89k | 100% | Dec 2023 |
|
| EverSource Wealth Advisors | 786.00 | $19k | 0% | Mar 2024 |
|
| IFP Advisors | 650.00 | $15k | 0% | Dec 2023 |
|
| Able Wealth Management | 83.00 | $2.0k | 100% | Dec 2023 |
|
| Federated Investors | 3.00 | $71.000100 | 100% | Dec 2023 |
|
| Activest Wealth Management | 0 | $0 | -100% | Mar 2024 |
|